Cargando…

Naringin Protects against Tau Hyperphosphorylation in Aβ(25–35)-Injured PC12 Cells through Modulation of ER, PI3K/AKT, and GSK-3β Signaling Pathways

Alzheimer's disease (AD) is the most common form of dementia and a significant social and economic burden. Estrogens can exert neuroprotective effects and may contribute to the prevention, attenuation, or even delay in the onset of AD; however, long-term estrogen therapy is associated with harm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Qi, Lei, Xia, Wang, Yueying, Xiong, Hui, Xu, Yanming, Sun, Huifeng, Xu, Hongdan, Zhang, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946756/ https://www.ncbi.nlm.nih.gov/pubmed/36844418 http://dx.doi.org/10.1155/2023/1857330

Ejemplares similares

Protective mechanism of kaempferol against Aβ(25-35)-mediated apoptosis of pheochromocytoma (PC-12) cells through the ER/ERK/MAPK signalling pathway
por: Zhang, Ning, et al.
Publicado: (2020)

GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions
por: Zhu, Huazhang, et al.
Publicado: (2018)

GSK-3β and ERK1/2 incongruously act in tau hyperphosphorylation in SPS-induced PTSD rats
por: Wei, Zhen, et al.
Publicado: (2019)

Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease
por: Jin, Nana, et al.
Publicado: (2015)

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease
por: Zhang, Bei, et al.
Publicado: (2016)

Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β
por: Park, Jin-Hee, et al.
Publicado: (2023)

Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3β Pathway in Experimental Models of Alzheimer's Disease
por: Yang, Wen, et al.
Publicado: (2020)

Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT(1A) receptor mediated Akt/GSK-3β pathway
por: Wang, Yan-Juan, et al.
Publicado: (2016)

The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells
por: Abdul, Ata ur Rahman Mohammed, et al.
Publicado: (2017)

Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling
por: Yang, Cuicui, et al.
Publicado: (2018)

Curcumin Downregulates GSK3 and Cdk5 in Scopolamine-Induced Alzheimer’s Disease Rats Abrogating Aβ(40/42) and Tau Hyperphosphorylation
por: Das, Tushar Kanti, et al.
Publicado: (2019)

Mangostanaxanthone IV Ameliorates Streptozotocin-Induced Neuro-Inflammation, Amyloid Deposition, and Tau Hyperphosphorylation via Modulating PI3K/Akt/GSK-3β Pathway
por: Abdallah, Hossam M., et al.
Publicado: (2021)

Direct High Affinity Interaction between Aβ42 and GSK3α Stimulates Hyperphosphorylation of Tau. A New Molecular Link in Alzheimer’s Disease?
por: Dunning, Christopher J., et al.
Publicado: (2015)

Inhibitory Effects of Auraptene and Naringin on Astroglial Activation, Tau Hyperphosphorylation, and Suppression of Neurogenesis in the Hippocampus of Streptozotocin-Induced Hyperglycemic Mice
por: Okuyama, Satoshi, et al.
Publicado: (2018)

Long-term depression links amyloid-β to the pathological hyperphosphorylation of tau
por: Taylor, Henry B.C., et al.
Publicado: (2021)

GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
por: Toral-Rios, Danira, et al.
Publicado: (2020)

Naringin attenuates acute myocardial ischemia-reperfusion injury via miR- 126/GSK-3β/β-catenin signaling pathway
por: Guo, Xiuhui, et al.
Publicado: (2022)

Extracellular α-Synuclein Leads to Microtubule Destabilization via GSK-3β-Dependent Tau Phosphorylation in PC12 Cells
por: Gąssowska, Magdalena, et al.
Publicado: (2014)

The role of CDK5 and GSK3B kinases in hyperphosphorylation of microtubule associated protein tau (MAPT) in Alzheimer's disease
por: Jayapalan, Saranya, et al.
Publicado: (2013)

Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β
por: Vossel, Keith A., et al.
Publicado: (2015)

Hyperphosphorylation-Induced Tau Oligomers
por: Iqbal, Khalid, et al.
Publicado: (2013)

Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease
por: Pascoal, T A, et al.
Publicado: (2017)

Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer’s disease
por: Borin, Mirta, et al.
Publicado: (2018)

DHCR24 Knock-Down Induced Tau Hyperphosphorylation at Thr181, Ser199, Thr231, Ser262, Ser396 Epitopes and Inhibition of Autophagy by Overactivation of GSK3β/mTOR Signaling
por: Bai, Xiaojing, et al.
Publicado: (2021)

Tau phosphorylation by GSK-3β promotes tangle-like filament morphology
por: Rankin, Carolyn A, et al.
Publicado: (2007)

The Interplay between GSK3β and Tau Ser262 Phosphorylation during the Progression of Tau Pathology
por: Song, Liqing, et al.
Publicado: (2022)

Activated gliosis, accumulation of amyloid β, and hyperphosphorylation of tau in aging canines with and without cognitive decline
por: Hines, Amelia D., et al.
Publicado: (2023)

MiR-124-3p attenuates hyperphosphorylation of tau protein-induced apoptosis via caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells
por: Kang, Qingmei, et al.
Publicado: (2017)

GSK3β Is Involved in the Relief of Mitochondria Pausing in a Tau-Dependent Manner
por: Llorens-Martín, María, et al.
Publicado: (2011)

Hsp90 Maintains the Stability and Function of the Tau Phosphorylating Kinase GSK3β
por: Dou, Fei, et al.
Publicado: (2007)

Different expression of GSK3β and pS9GSK3β depending on phenotype of cervical cancer: possible association of GSK3β with squamous cell carcinoma and pS9GSK3β with adenocarcinoma
por: Ahn, Kwanghee, et al.
Publicado: (2019)

Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells
por: Gao, Ling, et al.
Publicado: (2020)

Novel Reporter Alleles of GSK-3α and GSK-3β
por: Barrell, William B., et al.
Publicado: (2012)

Overexpression of GSK-3β in Adult Tet-OFF GSK-3β Transgenic Mice, and Not During Embryonic or Postnatal Development, Induces Tau Phosphorylation, Neurodegeneration and Learning Deficits
por: Rodríguez-Matellán, Alberto, et al.
Publicado: (2020)

Indirubin-3′-monoxime suppresses amyloid-beta-induced apoptosis by inhibiting tau hyperphosphorylation
por: Zhang, Shu-gang, et al.
Publicado: (2016)

Neuronal Deposition of Amyloid-β Oligomers and Hyperphosphorylated Tau Is Closely Connected with Cognitive Dysfunction in Aged Dogs
por: Habiba, Umma, et al.
Publicado: (2021)

Berberine Reduces Aβ(42) Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress
por: Wu, Yue, et al.
Publicado: (2021)

Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation
por: Ochalek, Anna, et al.
Publicado: (2017)

GSK-3β phosphorylation of functionally distinct tau isoforms has differential, but mild effects
por: Voss, Kellen, et al.
Publicado: (2009)

Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β
por: Povellato, Giulia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fl1edm6o9jgkqd9o09qmv5td7t